Loading
Healthcare
10 min read
Areas of Expertise :
Medical Malpractice, Internal Medicine, Gastroenterology, Pharmacology, Dermatology, Standard of Care, Healthcare
Published Date:
Last Modified Date:
Jurisdiction:
New Jersey State
Court:
Wiggins v. Hackensack Meridian Health, 259 N.J. 562 (2025), involved a New Jersey medical malpractice action brought by Earneka Wiggins and Lynda Myers, as administrators of the Estate of April Carden. The defendants included Hackensack Meridian Health doing business as JFK University Medical Center, Dr. Alok Goyal, and South Plainfield Primary Care. The plaintiffs alleged that Carden developed Stevens-Johnson syndrome after Dr. Goyal prescribed allopurinol in 2020 and that the medication contributed to complications preceding her death. They claimed that Dr. Goyal departed from accepted standards of medical care and asserted vicarious liability claims against the institutional defendants.
The appeal concerned whether the plaintiffs had submitted a legally sufficient Affidavit of Merit, or AOM, under New Jersey law. Dr. Goyal was board certified in internal medicine and gastroenterology, while Dr. Stella Jones Fitzgibbons, who signed the plaintiffs' affidavit, was board certified in internal medicine. The dispute required the New Jersey courts to determine what specialty credentials an AOM physician must possess when the treatment at issue falls within more than one field practiced by the defendant.
In December 2015, Dr. Goyal prescribed tramadol to April Carden, and another physician prescribed allopurinol in January 2016. The plaintiffs alleged that Carden later experienced a severe allergic reaction to tramadol, allopurinol, or both and was diagnosed with Stevens-Johnson syndrome. She received treatment at JFK University Medical Center. This history later became part of the plaintiffs' allegations concerning the allopurinol prescription attributed to Dr. Goyal in 2020.
In August 2020, Carden was treated at JFK after a fall and was diagnosed with a blood clot before being discharged on September 3. According to the complaint, Dr. Goyal prescribed allopurinol, which Carden took from September 4 through September 8. The plaintiffs alleged that the medication triggered another episode of Stevens-Johnson syndrome, leading to Carden's readmission to JFK on September 9.
After approximately ten days at JFK, Carden was transferred to a burn center. She died on September 29 from cardiopulmonary arrest associated with multiple organ failure, bacteremia, and Stevens-Johnson syndrome. The plaintiffs alleged that allopurinol was contraindicated in light of her medical history and that Dr. Goyal's prescribing decision contributed to her injuries and death.
On September 21, 2022, Dr. Goyal and South Plainfield Primary Care filed an answer stating under New Jersey Rule 4:5-3 that Carden's treatment involved internal medicine and gastroenterology. On November 10, the plaintiffs served an Affidavit of Merit signed by Dr. Stella Jones Fitzgibbons, who was board certified in internal medicine. She stated that there was a reasonable probability that the defendants' conduct fell outside accepted professional standards.
Defense counsel challenged the affidavit because Dr. Fitzgibbons did not also hold gastroenterology credentials. The parties addressed the disagreement during a November 28 Ferreira conference concerning compliance with New Jersey's Affidavit of Merit requirements.
On December 12, Dr. Goyal certified that he had treated Carden in his capacities as both an internist and a gastroenterologist, referring in part to aspects of her prior gastrointestinal care. On December 21, Dr. Goyal and South Plainfield Primary Care moved to dismiss the complaint for failure to comply with the Affidavit of Merit statute.
An Essex County judge transferred the case to Union County on December 22, and JFK later cross-moved for dismissal on similar grounds. Dr. Fitzgibbons also submitted a December 22 certification stating that she knew of no gastrointestinal condition treated with allopurinol and that Carden's reported elevated uric acid levels were not gastrointestinal in nature. The dispute centered on whether the AOM physician had to possess credentials in every field identified by Dr. Goyal or only in a specialty applicable to the treatment at issue.
On May 9, 2023, the trial court denied the defendants' motions to dismiss. It determined that the alleged allopurinol prescription involved internal medicine and that Dr. Fitzgibbons's qualifications were sufficient for purposes of the Affidavit of Merit statute.
The court also relied on Buck v. Henry, a New Jersey Supreme Court decision addressing specialty requirements when a physician practices in more than one field. The malpractice action was allowed to continue without requiring the plaintiffs to obtain an affidavit from a physician board certified in both internal medicine and gastroenterology.
Dr. Goyal moved for reconsideration and submitted a certification from Dr. Meyer N. Solny, who was board certified in internal medicine and gastroenterology. Dr. Solny stated that allopurinol has uses in gastroenterology, that gastroenterologists prescribe the medication, and that his medical knowledge as a gastroenterologist could not be separated from his knowledge as an internist.
On June 29, 2023, the trial court denied reconsideration and left its earlier ruling intact. The defendants were later granted leave to appeal.
The New Jersey Appellate Division reversed the trial court on April 18, 2024. It concluded that because Dr. Goyal was board certified in internal medicine and gastroenterology and stated that both fields were involved in Carden's care, the plaintiffs needed an AOM from a physician board certified in both areas.
The panel also determined that the portion of Buck v. Henry relied on by the trial court did not control the dispute. It remanded the matter for consideration of whether the plaintiffs qualified for a statutory waiver.
The Supreme Court of New Jersey granted the plaintiffs leave to appeal on July 18, 2024. During oral argument on November 4, the Court considered how N.J.S.A. 2A:53A-41 applies when a defendant physician practices in multiple specialties or subspecialties and the disputed treatment falls within more than one of them.
The parties also addressed the Court's earlier decision in Buck v. Henry and the relationship between the defendant's credentials, the treatment involved, and the qualifications required of an AOM physician.
On January 22, 2025, the Supreme Court unanimously reversed the Appellate Division, with Justice Douglas M. Fasciale writing for the Court. The Court held that when a defendant practices in more than one specialty or subspecialty and the treatment at issue falls within multiple applicable fields, an AOM physician qualified in one of those fields can satisfy the statutory credential requirement.
Because internal medicine was one of the fields Dr. Goyal identified in connection with Carden's treatment, Dr. Fitzgibbons's qualifications satisfied the statute. The Court reinstated the trial court orders denying dismissal and reconsideration and remanded the malpractice action for further proceedings.
Supreme Court of New Jersey
Case Name:
Wiggins v. Hackensack Meridian Health
Adverse Event
Hospital Malpractice
Medical Staff Credentialing
Prescriptions
Drug interactions
Vicarious Liability
Skin Disease
Wiggins v. Hackensack Meridian Health, 259 N.J. 562 (2025), involved a New Jersey medical malpractice action brought by Earneka Wiggins and Lynda Myers, as administrators of the Estate of April Carden. The defendants included Hackensack Meridian Health doing business as JFK University Medical Center, Dr. Alok Goyal, and South Plainfield Primary Care. The plaintiffs alleged that Carden developed Stevens-Johnson syndrome after Dr. Goyal prescribed allopurinol in 2020 and that the medication contributed to complications preceding her death. They claimed that Dr. Goyal departed from accepted standards of medical care and asserted vicarious liability claims against the institutional defendants.
The appeal concerned whether the plaintiffs had submitted a legally sufficient Affidavit of Merit, or AOM, under New Jersey law. Dr. Goyal was board certified in internal medicine and gastroenterology, while Dr. Stella Jones Fitzgibbons, who signed the plaintiffs' affidavit, was board certified in internal medicine. The dispute required the New Jersey courts to determine what specialty credentials an AOM physician must possess when the treatment at issue falls within more than one field practiced by the defendant.
In December 2015, Dr. Goyal prescribed tramadol to April Carden, and another physician prescribed allopurinol in January 2016. The plaintiffs alleged that Carden later experienced a severe allergic reaction to tramadol, allopurinol, or both and was diagnosed with Stevens-Johnson syndrome. She received treatment at JFK University Medical Center. This history later became part of the plaintiffs' allegations concerning the allopurinol prescription attributed to Dr. Goyal in 2020.
In August 2020, Carden was treated at JFK after a fall and was diagnosed with a blood clot before being discharged on September 3. According to the complaint, Dr. Goyal prescribed allopurinol, which Carden took from September 4 through September 8. The plaintiffs alleged that the medication triggered another episode of Stevens-Johnson syndrome, leading to Carden's readmission to JFK on September 9.
After approximately ten days at JFK, Carden was transferred to a burn center. She died on September 29 from cardiopulmonary arrest associated with multiple organ failure, bacteremia, and Stevens-Johnson syndrome. The plaintiffs alleged that allopurinol was contraindicated in light of her medical history and that Dr. Goyal's prescribing decision contributed to her injuries and death.
On September 21, 2022, Dr. Goyal and South Plainfield Primary Care filed an answer stating under New Jersey Rule 4:5-3 that Carden's treatment involved internal medicine and gastroenterology. On November 10, the plaintiffs served an Affidavit of Merit signed by Dr. Stella Jones Fitzgibbons, who was board certified in internal medicine. She stated that there was a reasonable probability that the defendants' conduct fell outside accepted professional standards.
Defense counsel challenged the affidavit because Dr. Fitzgibbons did not also hold gastroenterology credentials. The parties addressed the disagreement during a November 28 Ferreira conference concerning compliance with New Jersey's Affidavit of Merit requirements.
On December 12, Dr. Goyal certified that he had treated Carden in his capacities as both an internist and a gastroenterologist, referring in part to aspects of her prior gastrointestinal care. On December 21, Dr. Goyal and South Plainfield Primary Care moved to dismiss the complaint for failure to comply with the Affidavit of Merit statute.
An Essex County judge transferred the case to Union County on December 22, and JFK later cross-moved for dismissal on similar grounds. Dr. Fitzgibbons also submitted a December 22 certification stating that she knew of no gastrointestinal condition treated with allopurinol and that Carden's reported elevated uric acid levels were not gastrointestinal in nature. The dispute centered on whether the AOM physician had to possess credentials in every field identified by Dr. Goyal or only in a specialty applicable to the treatment at issue.
On May 9, 2023, the trial court denied the defendants' motions to dismiss. It determined that the alleged allopurinol prescription involved internal medicine and that Dr. Fitzgibbons's qualifications were sufficient for purposes of the Affidavit of Merit statute.
The court also relied on Buck v. Henry, a New Jersey Supreme Court decision addressing specialty requirements when a physician practices in more than one field. The malpractice action was allowed to continue without requiring the plaintiffs to obtain an affidavit from a physician board certified in both internal medicine and gastroenterology.
Dr. Goyal moved for reconsideration and submitted a certification from Dr. Meyer N. Solny, who was board certified in internal medicine and gastroenterology. Dr. Solny stated that allopurinol has uses in gastroenterology, that gastroenterologists prescribe the medication, and that his medical knowledge as a gastroenterologist could not be separated from his knowledge as an internist.
On June 29, 2023, the trial court denied reconsideration and left its earlier ruling intact. The defendants were later granted leave to appeal.
The New Jersey Appellate Division reversed the trial court on April 18, 2024. It concluded that because Dr. Goyal was board certified in internal medicine and gastroenterology and stated that both fields were involved in Carden's care, the plaintiffs needed an AOM from a physician board certified in both areas.
The panel also determined that the portion of Buck v. Henry relied on by the trial court did not control the dispute. It remanded the matter for consideration of whether the plaintiffs qualified for a statutory waiver.
The Supreme Court of New Jersey granted the plaintiffs leave to appeal on July 18, 2024. During oral argument on November 4, the Court considered how N.J.S.A. 2A:53A-41 applies when a defendant physician practices in multiple specialties or subspecialties and the disputed treatment falls within more than one of them.
The parties also addressed the Court's earlier decision in Buck v. Henry and the relationship between the defendant's credentials, the treatment involved, and the qualifications required of an AOM physician.
On January 22, 2025, the Supreme Court unanimously reversed the Appellate Division, with Justice Douglas M. Fasciale writing for the Court. The Court held that when a defendant practices in more than one specialty or subspecialty and the treatment at issue falls within multiple applicable fields, an AOM physician qualified in one of those fields can satisfy the statutory credential requirement.
Because internal medicine was one of the fields Dr. Goyal identified in connection with Carden's treatment, Dr. Fitzgibbons's qualifications satisfied the statute. The Court reinstated the trial court orders denying dismissal and reconsideration and remanded the malpractice action for further proceedings.
Dr. Stella Jones Fitzgibbons, who was board certified in internal medicine, provided the plaintiffs' Affidavit of Merit. Her qualifications became central to the litigation because the courts had to determine whether her internal medicine credentials were sufficient when Dr. Goyal identified both internal medicine and gastroenterology as fields involved in Carden's treatment.
Her internal medicine background was relevant to adult medical care, medication prescribing, patient history, and the consideration of prior adverse drug reactions in evaluating the treatment at issue.
Dr. Meyer N. Solny, who was board certified in internal medicine and gastroenterology, submitted a certification in support of Dr. Goyal's motion for reconsideration. He stated that allopurinol has uses in gastroenterology, that gastroenterologists prescribe the medication, and that his knowledge as a gastroenterologist could not be separated from his knowledge as an internist.
His certification supported the defendants' position that the treatment implicated both specialties and that the qualifications required of the plaintiffs' AOM physician should correspond to both fields.
Clinical pharmacology expertise may be relevant to questions involving allopurinol's indications, contraindications, adverse reactions, drug interactions, and a patient's prior medication history. This field can also address prescribing decisions when a malpractice case involves a suspected medication-related reaction.
Dermatology expertise may be relevant to the diagnosis, progression, and treatment of Stevens-Johnson syndrome and other severe reactions affecting the skin and mucous membranes. A dermatologist may also assess symptom timing and clinical findings when determining whether a medication was associated with the development of the condition.
New Jersey's Affidavit of Merit statute generally requires a plaintiff pursuing a malpractice or negligence claim against a covered licensed professional to provide an affidavit from an appropriately qualified professional. In a medical malpractice action, the affidavit must state that there is a reasonable probability that the defendant's care, skill, or knowledge fell outside acceptable professional standards.
The affidavit serves as an early procedural screening requirement. It does not determine whether malpractice ultimately occurred.
N.J.S.A. 2A:53A-41 sets qualification requirements for physicians who provide affidavits in malpractice actions involving specialists. The statute connects the affiant's qualifications to the specialty or subspecialty involved in the treatment that forms the basis of the claim.
In Wiggins, the Supreme Court addressed how that requirement applies when the defendant practices in several fields and the same disputed treatment can fall within more than one of them.
New Jersey Rule 4:5-3 requires a physician defending a malpractice action who admits treating the plaintiff to identify the field of medicine in which the physician specialized at the time, if any, and state whether the treatment involved that specialty.
Dr. Goyal identified internal medicine and gastroenterology. That statement shaped the later dispute over what qualifications the physician signing the plaintiffs' Affidavit of Merit was required to possess.
An Affidavit of Merit addresses whether a malpractice claim has sufficient professional support to proceed at an early stage of litigation. It does not establish that the defendant breached the standard of care.
A plaintiff must still prove the applicable standard of care, a departure from that standard, causation, and legally compensable damages as the case proceeds.
A physician's board certifications identify areas in which the physician has obtained recognized specialty credentials, but an Affidavit of Merit analysis also considers the field involved in the treatment that forms the basis of the alleged malpractice.
In Wiggins, Dr. Goyal held certifications in internal medicine and gastroenterology. The legal dispute developed because the parties disagreed over whether an AOM physician needed to match both fields when the challenged treatment could fall within more than one area of medical practice.
The New Jersey Supreme Court resolved the Affidavit of Merit dispute by reinstating the trial court's orders denying dismissal and reconsideration. Its January 22, 2025 decision allowed the plaintiffs' malpractice action to continue based on Dr. Fitzgibbons's internal medicine qualifications, while leaving the separate questions of negligence, medical causation, and liability for further proceedings.
What did the New Jersey Supreme Court decide in Wiggins v. Hackensack Meridian Health?
The Court held that an Affidavit of Merit physician does not necessarily have to match every specialty or subspecialty practiced by the defendant. When the disputed treatment falls within several applicable fields, qualification in one of those fields can satisfy the statutory requirement.
Why did the Appellate Division reject the plaintiffs' Affidavit of Merit?
The Appellate Division concluded that the affiant needed credentials corresponding to both internal medicine and gastroenterology because Dr. Goyal identified both fields as part of Carden's treatment. The New Jersey Supreme Court later rejected that interpretation.
Who provided the Affidavit of Merit in the Wiggins case?
Dr. Stella Jones Fitzgibbons provided the plaintiffs' Affidavit of Merit. She was board certified in internal medicine, which was one of the fields Dr. Goyal identified in connection with Carden's care.
What is a Ferreira conference in a New Jersey medical malpractice case?
A Ferreira conference is used to address compliance with New Jersey's Affidavit of Merit requirements early in a malpractice action. In Wiggins, the parties discussed the disagreement over Dr. Fitzgibbons's specialty qualifications during such a conference.
What role did allopurinol play in the Wiggins malpractice allegations?
The plaintiffs alleged that allopurinol triggered Carden's 2020 episode of Stevens-Johnson syndrome and contributed to the complications preceding her death. Those medical causation allegations remained part of the underlying malpractice action after the Supreme Court resolved the separate Affidavit of Merit issue.
Dr. Stella Jones Fitzgibbons, who was board certified in internal medicine, provided the plaintiffs' Affidavit of Merit. Her qualifications became central to the litigation because the courts had to determine whether her internal medicine credentials were sufficient when Dr. Goyal identified both internal medicine and gastroenterology as fields involved in Carden's treatment.
Her internal medicine background was relevant to adult medical care, medication prescribing, patient history, and the consideration of prior adverse drug reactions in evaluating the treatment at issue.
Dr. Meyer N. Solny, who was board certified in internal medicine and gastroenterology, submitted a certification in support of Dr. Goyal's motion for reconsideration. He stated that allopurinol has uses in gastroenterology, that gastroenterologists prescribe the medication, and that his knowledge as a gastroenterologist could not be separated from his knowledge as an internist.
His certification supported the defendants' position that the treatment implicated both specialties and that the qualifications required of the plaintiffs' AOM physician should correspond to both fields.
Clinical pharmacology expertise may be relevant to questions involving allopurinol's indications, contraindications, adverse reactions, drug interactions, and a patient's prior medication history. This field can also address prescribing decisions when a malpractice case involves a suspected medication-related reaction.
Dermatology expertise may be relevant to the diagnosis, progression, and treatment of Stevens-Johnson syndrome and other severe reactions affecting the skin and mucous membranes. A dermatologist may also assess symptom timing and clinical findings when determining whether a medication was associated with the development of the condition.
New Jersey's Affidavit of Merit statute generally requires a plaintiff pursuing a malpractice or negligence claim against a covered licensed professional to provide an affidavit from an appropriately qualified professional. In a medical malpractice action, the affidavit must state that there is a reasonable probability that the defendant's care, skill, or knowledge fell outside acceptable professional standards.
The affidavit serves as an early procedural screening requirement. It does not determine whether malpractice ultimately occurred.
N.J.S.A. 2A:53A-41 sets qualification requirements for physicians who provide affidavits in malpractice actions involving specialists. The statute connects the affiant's qualifications to the specialty or subspecialty involved in the treatment that forms the basis of the claim.
In Wiggins, the Supreme Court addressed how that requirement applies when the defendant practices in several fields and the same disputed treatment can fall within more than one of them.
New Jersey Rule 4:5-3 requires a physician defending a malpractice action who admits treating the plaintiff to identify the field of medicine in which the physician specialized at the time, if any, and state whether the treatment involved that specialty.
Dr. Goyal identified internal medicine and gastroenterology. That statement shaped the later dispute over what qualifications the physician signing the plaintiffs' Affidavit of Merit was required to possess.
An Affidavit of Merit addresses whether a malpractice claim has sufficient professional support to proceed at an early stage of litigation. It does not establish that the defendant breached the standard of care.
A plaintiff must still prove the applicable standard of care, a departure from that standard, causation, and legally compensable damages as the case proceeds.
A physician's board certifications identify areas in which the physician has obtained recognized specialty credentials, but an Affidavit of Merit analysis also considers the field involved in the treatment that forms the basis of the alleged malpractice.
In Wiggins, Dr. Goyal held certifications in internal medicine and gastroenterology. The legal dispute developed because the parties disagreed over whether an AOM physician needed to match both fields when the challenged treatment could fall within more than one area of medical practice.
The New Jersey Supreme Court resolved the Affidavit of Merit dispute by reinstating the trial court's orders denying dismissal and reconsideration. Its January 22, 2025 decision allowed the plaintiffs' malpractice action to continue based on Dr. Fitzgibbons's internal medicine qualifications, while leaving the separate questions of negligence, medical causation, and liability for further proceedings.
What did the New Jersey Supreme Court decide in Wiggins v. Hackensack Meridian Health?
The Court held that an Affidavit of Merit physician does not necessarily have to match every specialty or subspecialty practiced by the defendant. When the disputed treatment falls within several applicable fields, qualification in one of those fields can satisfy the statutory requirement.
Why did the Appellate Division reject the plaintiffs' Affidavit of Merit?
The Appellate Division concluded that the affiant needed credentials corresponding to both internal medicine and gastroenterology because Dr. Goyal identified both fields as part of Carden's treatment. The New Jersey Supreme Court later rejected that interpretation.
Who provided the Affidavit of Merit in the Wiggins case?
Dr. Stella Jones Fitzgibbons provided the plaintiffs' Affidavit of Merit. She was board certified in internal medicine, which was one of the fields Dr. Goyal identified in connection with Carden's care.
What is a Ferreira conference in a New Jersey medical malpractice case?
A Ferreira conference is used to address compliance with New Jersey's Affidavit of Merit requirements early in a malpractice action. In Wiggins, the parties discussed the disagreement over Dr. Fitzgibbons's specialty qualifications during such a conference.
What role did allopurinol play in the Wiggins malpractice allegations?
The plaintiffs alleged that allopurinol triggered Carden's 2020 episode of Stevens-Johnson syndrome and contributed to the complications preceding her death. Those medical causation allegations remained part of the underlying malpractice action after the Supreme Court resolved the separate Affidavit of Merit issue.
Adverse Event
Hospital Malpractice
Medical Staff Credentialing
Prescriptions
Drug interactions
Vicarious Liability
Skin Disease
Medical Devices, +4
Healthcare
Healthcare, +4
Healthcare